These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 23950881)
1. Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth. Wang CF; Zhang G; Zhao LJ; Qi WJ; Li XP; Wang JL; Wei LH PLoS One; 2013; 8(8):e69001. PubMed ID: 23950881 [TBL] [Abstract][Full Text] [Related]
2. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma]. Zhang G; Li XP; Wang JL; Wei LH Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125 [TBL] [Abstract][Full Text] [Related]
3. Effects of insulin, insulin-like growth factor-I and -II on proliferation and intracellular signaling in endometrial carcinoma cells with different expression levels of insulin receptor isoform A. Wang CF; Zhang G; Zhao LJ; Li XP; Qi WJ; Wang JL; Wei LH Chin Med J (Engl); 2013; 126(8):1560-6. PubMed ID: 23595395 [TBL] [Abstract][Full Text] [Related]
4. Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway. Dong L; Du M; Lv Q Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):753-760. PubMed ID: 31168597 [TBL] [Abstract][Full Text] [Related]
5. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice]. Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587 [TBL] [Abstract][Full Text] [Related]
6. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways. Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438 [TBL] [Abstract][Full Text] [Related]
8. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells. Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274 [TBL] [Abstract][Full Text] [Related]
9. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells. Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597 [TBL] [Abstract][Full Text] [Related]
10. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway. Lin Q; Chen H; Zhang M; Xiong H; Jiang Q Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003 [TBL] [Abstract][Full Text] [Related]
11. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation. Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757 [TBL] [Abstract][Full Text] [Related]
12. Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma. Flannery CA; Saleh FL; Choe GH; Selen DJ; Kodaman PH; Kliman HJ; Wood TL; Taylor HS J Clin Endocrinol Metab; 2016 Jul; 101(7):2883-91. PubMed ID: 27088794 [TBL] [Abstract][Full Text] [Related]
13. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Gao J; Tian J; Lv Y; Shi F; Kong F; Shi H; Zhao L Cancer Sci; 2009 Mar; 100(3):389-95. PubMed ID: 19154413 [TBL] [Abstract][Full Text] [Related]
14. Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α. Kojima M; Sugimoto K; Kobayashi M; Ichikawa-Tomikawa N; Kashiwagi K; Watanabe T; Soeda S; Fujimori K; Chiba H Mol Cancer Res; 2021 Jul; 19(7):1208-1220. PubMed ID: 33727343 [TBL] [Abstract][Full Text] [Related]
15. LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway. Zhang Z; Liu X; Xu H; Li P; Zeng T; Du W; Lu X J BUON; 2018; 23(6):1745-1752. PubMed ID: 30610803 [TBL] [Abstract][Full Text] [Related]
16. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. He YY; Cai B; Yang YX; Liu XL; Wan XP Cancer Sci; 2009 Jun; 100(6):1051-61. PubMed ID: 19432902 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells. Liu C; Xing G; Wu C; Zhu J; Wei M; Liu D; Ge Y; Chen Y; Lei T; Yang Y Med Sci Monit; 2018 Mar; 24():1836-1846. PubMed ID: 29595187 [TBL] [Abstract][Full Text] [Related]
18. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2. Sun Y; Wang C; Yang H; Ma X Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805 [TBL] [Abstract][Full Text] [Related]
19. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer. Zhou L; Cai B; Bao W; He YY; Chen XY; Yang YX; Liu XL; Wan XP Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253 [TBL] [Abstract][Full Text] [Related]
20. lncRNA DLEU1 contributes to tumorigenesis and development of endometrial carcinoma by targeting mTOR. Du Y; Wang L; Chen S; Liu Y; Zhao Y Mol Carcinog; 2018 Sep; 57(9):1191-1200. PubMed ID: 29745433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]